This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genfit. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Christophe Masson: Innovator in PPAR Agonist Compounds
Introduction
Christophe Masson is a notable inventor based in Chateaudun, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of PPAR agonist compounds. His work is aimed at addressing critical health issues such as diabetes and cardiovascular diseases.
Latest Patents
Christophe Masson holds a patent for PPAR agonist compounds, which includes their preparation and uses. The present invention relates to novel PPAR agonist compounds as well as pharmaceutical compositions containing them. These compounds are of particular therapeutic interest, notably for treating diabetes and/or dyslipidemias, as well as for preventing cardiovascular pathologies. He has 1 patent to his name.
Career Highlights
Masson is associated with Genfit, a company that focuses on developing innovative therapies for metabolic diseases. His role at Genfit has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
One of his notable coworkers is Karine Caumont-Bertrand, with whom he collaborates on various projects within the company.
Conclusion
Christophe Masson is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on PPAR agonist compounds. His contributions are vital for advancing treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile